(Q52925148)

9 May 2018

title

The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study. (English)

1 reference

9 May 2018

multicenter clinical trial

main subject

multiple sclerosis

0 references

1 reference

P D Molyneux

1

1 reference

9 May 2018

P A Brex

2

1 reference

9 May 2018

C Fogg

3

1 reference

9 May 2018

S Lewis

4

1 reference

9 May 2018

C Middleditch

5

1 reference

9 May 2018

F Barkhof

6

1 reference

9 May 2018

M P Sormani

7

1 reference

9 May 2018

M Filippi

8

1 reference

9 May 2018

D H Miller

9

1 reference

9 May 2018

publication date

1 August 2000

1 reference

9 May 2018

Multiple Sclerosis Journal

published in

1 reference

9 May 2018

volume

6

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

237-240

1 reference

9 May 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

cites work

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245850000600405

10.1177/135245850000600405

21 January 2018

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018